Thiogenesis Therapeutics Corp Financial Overview
Thiogenesis Therapeutics Corp's market cap is currently C$29.03M. The company's EPS TTM is C$-0.05; its P/E ratio is -3.87; Thiogenesis Therapeutics Corp is scheduled to report earnings on November 26, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
